Background: Previous studies aimed at developing an artificial placenta have had limited success. We hypothesized that the introduction of a high-performance membranous oxygenator to a pumpless artificial placenta could prolong the survival time of premature lambs. Methods: Immediately after delivery of the fetuses, the umbilical vessels were cannulated and connected to the pumpless artificial placenta. Both the fetuses and the circuit were submerged in a warm saline bath. results: Five fetuses survived for 18.2 ± 3.2 (mean ± seM) h after attachment to the artificial placenta, which maintained fetal circulation. circuit blood flow was positively correlated with mean arterial pressure and negatively correlated with blood lactate levels. Milrinone administration transiently decreased lactate levels, although dopamine administration unexpectedly induced a marked increase in the lactate levels despite an elevated arterial pressure and improved circuit blood flow. conclusIon: We prolonged the survival of fetal lambs using a high-performance membranous oxygenator with a small priming volume. The increased systemic resistance induced by vasoconstrictors may increase the circuit blood flow excessively, resulting in circulation failure in systemic organs; therefore, vasodilators may be more useful than vasoconstrictors for maintaining organ blood flow within this circuit.d espite progress in neonatal intensive care, effective treatments for premature low-birth-weight infants with cardiopulmonary abnormalities are lacking. The use of an artificial placenta has been proposed, but previous studies have had limited success, possibly because the circuit volume was too large and the resistance of the circuit was too high (1-5). A more compact circuit may be a solution; in 2009, Reoma et al. reported a 4-h survival period using a pumpless artificial placenta for the first time (6). However, the fetuses could not survive for longer than 4 h because of fetal circulatory deterioration. The authors concluded that prolonging the survival time any further was difficult without the assistance of a roller pump.Is it impossible to prolong the survival time using a pumpless artificial placenta? The goal of our study was to prolong survival time by improving the following two points. First, we developed a high-performance membranous oxygenator jointly with the group of A. Funakubo, who is a pioneer in the development of the membranous oxygenator (7,8). Our membranous oxygenator enabled a reduction in priming volume of 40%, as compared with that used in Reoma's experiment (6), while maintaining membrane surface area. Second, we administered a vasodilator to the fetuses to maintain circulation in systemic organs. Table 1 compares the values obtained in Reoma's experiments (6) with those obtained in our study. The fetuses in our experimental group had a shorter gestational age, a lower birth weight, and a longer survival time than those in Reoma's experiment. In this study, five fetuses were successfully connected to the artificial placenta,...